Found 5 matching trials
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer
PHASE1The purpose of this study is to evaluate how safe PS-341(VELCADE) is when g...
Location
Cedars Sinai Medical Center
Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
PHASE2The purpose of this study is to evaluate how tumors in patients with colore...
Location
Cooper Green Hospital / Jefferson Clinic P.C.
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
PHASE2The overarching objective of this study is to use novel precision medicine ...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
PHASE1The purpose of this study is to evaluate how safe VELCADE (PS-341) is when ...
Location
Multiple Locations
VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
PHASE2The purpose of this study is to find out whether treatment with VELCADE wil...
Location
University of Alabama